Trial
NCT00380874
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Chemotherapy-Induced Peripheral Neuropathy
Intervention
Pregabalin
Why stopped
See detailed description for termination reason
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-11